Is to determine if SDM laser can reduce macular thickness in non central CSME and stop the progression of non central CSME to central CSME in compare to glycemic control
interventional randomised masked study will recruit patients have diabetes mellitus with non central CSME with good vision into two groups : 1st SDM laser with glycemic control 2nd SHAM laser with Glycemic control where BCVA will be recorded every month starting from baseline to 24 weeks where OCT will be recorded every 8 weeks from baseline to 24 weeks
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
8
Subthershold 532nm laser
Marashi Eye Clinic
Aleppo, Syria
Number of eyes with reduced macular thickness
Measurements of retinal thickness in the area of edema
Time frame: 24 weeks
Number of eyes with reduced vision
Best corrected visual acuity at the end of the study
Time frame: 24 weeks
Number of eyes developing central macular edema
Time frame: 24 weeks
Number of patients achieved good glycemic control
By measuring HbA1C every 12 weeks from baseline
Time frame: 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.